scGRNom: a computational pipeline of integrative multi-omics analyses for predicting cell-type disease genes and regulatory networks
Understanding cell-type-specific gene regulatory mechanisms from genetic variants to
diseases remains challenging. To address this, we developed a computational pipeline …
diseases remains challenging. To address this, we developed a computational pipeline …
Future therapeutics in Alzheimer's disease: development status of BACE inhibitors
G Evin - BioDrugs, 2016 - Springer
Alzheimer's disease (AD) is the primary cause of dementia in the elderly. It remains
incurable and poses a huge socio-economic challenge for developed countries with an …
incurable and poses a huge socio-economic challenge for developed countries with an …
[HTML][HTML] Alzheimer's disease: Amyloid-based pathogenesis and potential therapies
Y Zhou, Y Sun, QH Ma, Y Liu - Cell stress, 2018 - ncbi.nlm.nih.gov
Alzheimer's disease is one of the most severe neurodegenerative diseases among elderly
people. Different pathogenic factors for Alzheimer's disease have been posited and studied …
people. Different pathogenic factors for Alzheimer's disease have been posited and studied …
The vexing complexity of the amyloidogenic pathway
MA Castro, A Hadziselimovic, CR Sanders - Protein Science, 2019 - Wiley Online Library
The role of the amyloidogenic pathway in the etiology of Alzheimer's disease (AD),
particularly the common sporadic late onset forms of the disease, is controversial. To some …
particularly the common sporadic late onset forms of the disease, is controversial. To some …
Brain region-specific differences in amyloid-β plaque composition in 5XFAD mice
AS Bader, MU Gnädig, M Fricke, L Büschgens… - Life, 2023 - mdpi.com
Senile plaques consisting of amyloid-beta (Aβ) peptides are a major pathological hallmark
of Alzheimer's disease (AD). Aβ peptides are heterogeneous regarding the exact length of …
of Alzheimer's disease (AD). Aβ peptides are heterogeneous regarding the exact length of …
[HTML][HTML] A rare missense variant of CASP7 is associated with familial late-onset Alzheimer's disease
Introduction The genetic architecture of Alzheimer's disease (AD) is only partially
understood. Methods We conducted an association study for AD using whole sequence data …
understood. Methods We conducted an association study for AD using whole sequence data …
Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer's disease
Alzheimer's disease (AD) is thought to be caused by accumulation of amyloid-β protein (Aβ),
which is a cleavage product of amyloid precursor protein (APP). Transgenic mice …
which is a cleavage product of amyloid precursor protein (APP). Transgenic mice …
Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer's disease
F Aichholzer, HW Klafki, I Ogorek, J Vogelgsang… - Alzheimer's research & …, 2021 - Springer
Background Alzheimer's disease (AD) is a neurodegenerative disorder associated with
extracellular amyloid-β peptide deposition and progressive neuron loss. Strong evidence …
extracellular amyloid-β peptide deposition and progressive neuron loss. Strong evidence …
Lysosomal dysfunction in the brain of a mouse model with intraneuronal accumulation of carboxyl terminal fragments of the amyloid precursor protein
G Kaur, M Pawlik, SE Gandy, ME Ehrlich… - Molecular …, 2017 - nature.com
Recent data suggest that intraneuronal accumulation of metabolites of the amyloid-β-
precursor protein (APP) is neurotoxic. We observed that transgenic mice overexpressing in …
precursor protein (APP) is neurotoxic. We observed that transgenic mice overexpressing in …
Cyclin dependent kinase 5: A novel avenue for Alzheimer's disease
Alzheimer's disease (AD) is one of the most frequently encountered diseases in adults with
progressive loss of memory and behavioral changes. Inspite of there being an intense …
progressive loss of memory and behavioral changes. Inspite of there being an intense …